Skip to Main Content

Paper Details

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.
Blood
63
2022
-genome, Myeloid neoplasms, RNA, acute leukemia, acute leukemias, chromosomal, chromosomal abnormalities, germline gene, hematologic, hematologic neoplasms, hematopoietic cells, malignancies, myeloid, myeloid neoplasms, patients, targeted gene panels
Author NameAffiliation
Courtney D DiNardoMD Anderson Cancer Center
Lucy A GodleyThe University of Chicago
Siddhartha JaiswalStanford University
Luca MalcovatiUniversity of Pavia & Fondazione IRCCS Policlinico S. Matteo
Rafael BejarUniversity of California San Diego
Anna L Brown
Guillermo Garcia-ManeroMD Anderson Cancer Center
Torsten Haferlach
Jeffery M KlcoSt. Jude Children's Research Hospital
Mignon L LohBen Towne Center for Childhood Cancer Research, Seattle Children's Hospital, University of Washington
Charles G MullighanSt. Jude Children's Research Hospital
Seishi OgawaUniversity of Kyoto School of Medicine
Richard M StoneDana-Farber Cancer Institute, Harvard Medical School
Matthew J WalterWashington University
David WuUniversity of Washington
Benjamin L EbertDana-Farber Cancer Institute, Harvard Medical School
  • 1 - 16

Datasets

Release 1.2